Nerve Blocks Now Recommended For ER Migraine Treatment
THURSDAY, Dec. 11, 2025 People hospitalized for a debilitating migraine should receive targeted nerve blocks rather than IV opioids to quell their pain, accordi
This edition features Asahi’s focus on its beer adjacent categories and East Africa expansion, Calbee’s personalised granola, government investment into food technology, and more. Post Views: 2
The firm’s owner, Supreme, is repositioning SlimFast beyond weight loss, launching seven protein, fibre and collagen products aimed at GLP-1 users and everyday wellness Post Views: 2